US Broker Ratings

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential Amidst a 4.98% Upside

Novartis AG (NYSE: NVS), a leading player in the global healthcare sector, stands as a compelling investment opportunity with its extensive portfolio of innovative medicines and robust financial health. Headquartered..

Sanofi (SNY) Stock Analysis: Exploring a 21% Potential Upside and Robust Dividend Yield

Sanofi (SNY), a behemoth in the healthcare sector, continues to capture investor attention with its impressive market cap of $110.4 billion and a rich portfolio of therapeutic solutions. Headquartered in..

BeOne Medicines Ltd. (ONC): Investor Outlook with a Promising 38.91% Potential Upside

Investors eyeing the biotechnology sector should take note of BeOne Medicines Ltd. (ONC), a Swiss-based company making significant strides in oncology treatments. With a market cap of $32.66 billion and..

argenx SE (ARGX) Stock Analysis: Unpacking a 32% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX) is making waves in the biotechnology industry, offering intriguing opportunities for investors eyeing the healthcare sector. Based in the Netherlands, this commercial-stage biopharmaceutical company has carved..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 32.54% Potential Upside

Cencora, Inc. (COR), a key player in the healthcare sector specializing in medical distribution, presents an intriguing investment opportunity, underpinned by a combination of robust financial performance and favorable analyst..

Gilead Sciences, Inc. (GILD) Stock Analysis: Uncover 20% Potential Upside with Strong Buy Ratings

For investors eyeing the healthcare sector, Gilead Sciences, Inc. (NASDAQ: GILD) presents an enticing opportunity, with a potential upside of 20.29% as indicated by its average target price of $158.36...

Centene Corporation (CNC) Stock Analysis: Navigating the Healthcare Landscape with Strategic Resilience

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is renowned for its comprehensive managed care programs and services tailored for under-insured families and commercial organizations across the..

Mettler-Toledo International, Inc. (MTD): Analyst Ratings Signal Potential 17.46% Upside for Investors

Mettler-Toledo International, Inc. (NYSE: MTD), a Swiss-based leader in precision instruments, stands as a compelling entity within the Diagnostics & Research industry of the Healthcare sector. With a market capitalization..

Becton, Dickinson and Company (BDX): Analyst Ratings and 28% Potential Upside Signal Opportunity

For investors eyeing the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) stands out as a significant player, boasting a market capitalization of $42.47 billion. Known for its comprehensive range..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Navigating a 32% Potential Upside Amid Industry Leadership

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, is captivating investor attention with its robust market presence and a promising potential upside of 32.16%. With a..

GSK plc (GSK) Stock Analysis: Navigating a Potential 11.71% Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a leading player in the healthcare sector, continues to capture investor interest with its robust portfolio of vaccines and specialty medicines. With a market capitalization of..

Haleon plc (HLN) Stock Analysis: Unlocking a 25% Potential Upside in the Healthcare Sector

Haleon plc (NYSE: HLN), a formidable player in the healthcare sector, commands investor attention with its robust portfolio of consumer healthcare products. With a market cap of $41.69 billion, Haleon..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 54% Potential Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a powerhouse in health information services, is capturing investor attention with its robust market presence and a remarkable potential upside of 54.12%. As a leading..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 15.67% Potential Upside in the Healthcare Giant

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, with a robust market capitalization of $277.02 billion. Known for its wide array of pharmaceutical..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 10.15% Potential Upside Amidst Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a stalwart in the healthcare sector, with a market capitalization of $149.77 billion. As a major player in the drug manufacturing industry, Pfizer has..

Novo Nordisk A/S (NVO): Investor Outlook Reveals 6.24% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has long been synonymous with groundbreaking advancements in the pharmaceutical industry. With a robust market presence and a valuation..

Zoetis Inc. (ZTS) Stock Analysis: Robust Growth Potential with a 30% Upside

For investors seeking exposure in the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents a compelling opportunity with its strong market position in the animal health industry. With a market capitalization..

Amgen Inc. (AMGN) Stock Analysis: Exploring a 7.16% Upside Potential Amidst Robust Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a global leader in biotechnology, is captivating investors with a compelling narrative of steady growth, robust revenue figures, and a promising upside potential. With a market..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 50.77% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, is currently presenting an intriguing opportunity for investors. With a market capitalization of $83.97 billion,..

Prestige Consumer Healthcare (PBH) Stock Analysis: Unpacking a 33% Potential Upside for Investors

Prestige Consumer Healthcare Inc. (PBH) stands as a notable entity within the healthcare sector, specifically in the arena of specialty and generic drug manufacturing. With a market capitalization of $2.79..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds